ID: ALA5289201

Max Phase: Preclinical

Molecular Formula: C19H20Br2N4O3

Molecular Weight: 512.20

Associated Items:

Representations

Canonical SMILES:  O=[N+]([O-])c1cc2c(cc1Br)c1cc(Br)ccc1n2CC(O)CN1CCNCC1

Standard InChI:  InChI=1S/C19H20Br2N4O3/c20-12-1-2-17-14(7-12)15-8-16(21)19(25(27)28)9-18(15)24(17)11-13(26)10-23-5-3-22-4-6-23/h1-2,7-9,13,22,26H,3-6,10-11H2

Standard InChI Key:  QWOWGGGCFKPAQB-UHFFFAOYSA-N

Associated Targets(Human)

Apoptosis regulator BAX 73 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 512.20Molecular Weight (Monoisotopic): 509.9902AlogP: 3.49#Rotatable Bonds: 5
Polar Surface Area: 83.57Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.28CX LogP: 3.64CX LogD: 1.77
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.40Np Likeness Score: -1.08

References

1. Pogmore JP, Uehling D, Andrews DW..  (2021)  Pharmacological Targeting of Executioner Proteins: Controlling Life and Death.,  64  (9.0): [PMID:33939407] [10.1021/acs.jmedchem.0c02200]

Source